Pfizer
Pfizer reported 17 stocks worth $170M in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are ALLO (27.6%), CELC (17.4%) and ARVN (16.2%). Compared with Q1 2026, the fund trimmed ORIC, ZURA and NXTC and sold out of QTTB.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 7 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  ALLO Allogene Therapeutics Inc | $46.9M | 27.6% | 22M | No change | 7 of 7 | |
| 2 |  CELC Celcuity Inc | $29.6M | 17.4% | 296K | No change | 7 of 7 | |
| 3 |  ARVN Arvinas Inc | $27.7M | 16.2% | 3.5M | No change | 7 of 7 | |
| 4 |  PYXS Pyxis Oncology Inc | $19.5M | 11.4% | 7M | No change | 7 of 7 | |
| 5 |  WVE Wave Life Sciences Ltd | $10.9M | 6.4% | 1.9M | No change | 7 of 7 | |
| 6 |  BHVN Biohaven Ltd | $8M | 4.7% | 506K | No change | 7 of 7 | |
| 7 |  CRBU Caribou Biosciences Inc | $7.9M | 4.6% | 4.7M | No change | 7 of 7 | |
| 8 |  SPRO Spero Therapeutics Inc | $5.3M | 3.1% | 2.4M | No change | 7 of 7 | |
| 9 |  ZNTL Zentalis Pharmaceuticals Inc | $3.9M | 2.3% | 954K | No change | 7 of 7 | |
| 10 |  ORIC Oric Pharmaceuticals Inc | $3.6M | 2.1% | 373K | −4.4M (−92%) | 7 of 7 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 QTTB Q32 Bio Inc | $737K | 102K |
Reported value
last 7 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 13, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Pfizer 13F FAQ
What does Pfizer own?
Pfizer reported 17 stocks worth $170M in its 13F filing for Q2 2026, filed Aug 13, 2026. Its largest holdings are ALLO (27.6%), CELC (17.4%) and ARVN (16.2%). The table above lists every position in the filing (the top 10 without an account).
What did Pfizer buy and sell in Q2 2026?
Compared with Q1 2026: 0 new positions, 0 added to, 3 trimmed and 1 sold out. It sold all of QTTB.
When will Pfizer file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Pfizer's portfolio worth?
The Q2 2026 filing reports $170M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.